Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that, due to demand, the underwriter has agreed to...

from PR Newswire: https://ift.tt/3vSSdYU